GSK
GlaxoSmithKline PLC
50.50$
+0.3%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Cash Flow
All figures per share in GBP.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.08 | 1.76 | 0.58 | 0.54 | 1.06 | 1.12 | 0.55 | 1.02 | 1.48 | 1.00 | 0.56 | 1.25 | 4.30 | |
| 0.28 | 0.71 | 0.34 | 0.31 | 0.47 | 0.20 | 0.40 | 0.56 | 0.49 | 0.38 | 0.23 | 0.11 | 1.21 | |
| 0.15 | 0.15 | – | – | – | – | – | – | – | – | – | – | – | |
| -0.04 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.08 | 0.88 | -0.19 | -0.30 | -0.36 | 1.81 | -0.38 | -0.50 | -0.52 | 0.68 | -0.53 | -0.01 | -0.38 | |
| 0.24 | 0.29 | 0.15 | 0.21 | 0.41 | 0.55 | 0.22 | 0.31 | 0.21 | 0.27 | 0.22 | 0.16 | 0.87 | |
| -0.24 | 0.14 | -0.12 | 0.37 | -0.36 | -0.54 | -0.55 | -0.30 | -1.05 | -1.16 | -0.72 | -0.43 | -3.38 | |
| 0.28 | 0.33 | 0.35 | 0.32 | 0.30 | 0.30 | 0.30 | 0.32 | 0.44 | 0.31 | 0.32 | 0.36 | 1.43 | |
| 0.00 | -0.02 | – | 0.00 | 0.01 | 0.01 | -0.12 | -0.27 | -0.22 | -0.67 | -0.16 | -0.15 | -1.20 | |
| -0.53 | – | – | – | -0.27 | 0.12 | 0.93 | -0.43 | -0.04 | 0.27 | 0.58 | -0.31 | 0.50 | |
| -0.86 | -1.97 | -0.61 | -0.77 | -0.61 | -0.41 | 0.41 | -1.15 | -0.83 | 0.40 | 0.13 | -0.94 | -1.25 | |
| -0.01 | -0.07 | -0.11 | 0.14 | 0.07 | 0.18 | 0.41 | -0.45 | -0.24 | 0.05 | -0.03 | -0.15 | -0.37 | |
| 0.83 | 1.47 | 0.43 | 0.33 | 0.64 | 0.58 | 0.34 | 0.71 | 1.27 | 0.72 | 0.34 | 1.09 | 3.44 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.